ERIC LOUIS SCOFIELD
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WILMINGTON, NC NPI 1295017465
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NC PFIZER INC. All categories
General Payments — all program years on this page
$6,358.03
- Category: General Payments
- Program years: PY2021–2024
- Record count: 79
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,351.08 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $4,104.00 | 1 |
| Food and Beverage | $820.44 | 40 |
| Travel and Lodging | $276.64 | 1 |
| Education | $150.00 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $4,685.50 | 10 |
| Celgene Corporation | $79.93 | 5 |
| Acerta Pharma LLC | $62.53 | 3 |
| Janssen Biotech, Inc. | $59.21 | 3 |
| Daiichi Sankyo Inc. | $50.29 | 2 |
| Merck Sharp & Dohme Corporation | $47.79 | 2 |
| Astellas Pharma US Inc | $39.54 | 2 |
| EMD Serono, Inc. | $32.10 | 2 |
| BeiGene USA, Inc. | $26.22 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.01 | 1 |
| ABBVIE INC. | $22.31 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.90 | 1 |
| GlaxoSmithKline, LLC. | $21.27 | 1 |
| Agios Pharmaceuticals, Inc. | $21.04 | 1 |
| Exelixis Inc. | $20.12 | 1 |
| EISAI INC. | $18.74 | 1 |
| Genentech USA, Inc. | $18.46 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.28 | 1 |
| CARDINAL HEALTH 414 LLC | $16.63 | 1 |
| TerSera Therapeutics LLC | $16.51 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.21 | 1 |
| SERVIER PHARMACEUTICALS LLC | $15.88 | 1 |
| Mirati Therapeutics, Inc. | $15.61 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.